JBIO 10-Q: SEC filing
Jade Biosciences, Inc.
Filed with the SEC on · accession 0001193125-26-459293
JBIO filed a 10-Q (quarterly report) with the SEC on Nov 13, 2026. Jade Biosciences, Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2026, reporting financial results and business updates.
Summary of the filing
Jade Biosciences, Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2026, reporting financial results and business updates. The filing includes standard financial statements, equity activity, and disclosures related to its clinical-stage biopharmaceutical operations.
Key details
✦ Ask GOAX AI about this filing — what it means for JBIO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for JBIO?
Click hereFrequently asked questions
What did JBIO file with the SEC on Nov 13, 2026?
JBIO filed a 10-Q (SEC filing). Jade Biosciences, Inc. filed its quarterly report on Form 10-Q for the period ending September 30, 2026, reporting financial results and business updates. The filing includes standard financial statements, equity activity, and disclosures related to its clinical-stage biopharmaceutical operations.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other JBIO SEC filings
- 8-K · SEC filingNov 13, 2026
- SCHEDULE 13G · SEC filingOct 28, 2026
- SCHEDULE 13G · SEC filingOct 27, 2026
- 8-K · SEC filingSep 30, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · SEC filingAug 10, 2026
- 8-K · SEC filingAug 10, 2026
- 8-K · Material agreementJul 1, 2026
- 8-K · Board changeJun 26, 2026
Get alerts when JBIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days